February 20 – 22, 2017

Boston, USA

The 5th Annual World CNS Summit is back to share the latest advances in our understanding of the causes and mechanisms of neurodegenerative diseases. With an exclusive focus on empowering neurodegenerative translational and clinical research, this meeting will explore and challenge traditional thinking  in the development of efficacious treatments against neurodegeneration.

This is a unique opportunity to collaborate with leading scientists, consortia and pharmaceutical business leaders in tackling critical issues hindering the successful development of the next generation of therapeutics.

Join the conversation as we reveal unpublished discoveries, preclinical and clinical case studies that explore how to identify and validate clinically relevant biomarkers, improve the translatability of pre-clinical modeling systems and revolutionize clinical trial design to maximize the chance of drug approval.

Read more.

“Essentially every speaker was excellent. A very informative and thought provoking series of presentations.”

Patricia Walicke,
Medical Officer,
National Institute Neurologic Disease and Stroke

- World CNS Attendee

Linkedin 2